A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC

NCT01267344 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma
Adenocarcinoma of Gallbladder

Interventions

DRUG: gemcitabine, oxaliplatin
DRUG: cetuximab, gemcitabine, oxaliplatin

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]